159 related articles for article (PubMed ID: 26786600)
1. Novel organogels for topical delivery of naproxen: design, physicochemical characteristics and in vitro drug permeation.
Osmałek T; Milanowski B; Froelich A; Górska S; Białas W; Szybowicz M; Kapela M
Pharm Dev Technol; 2017 Jun; 22(4):521-536. PubMed ID: 26786600
[TBL] [Abstract][Full Text] [Related]
2. The impact of liposomes on transdermal permeation of naproxen--in vitro studies.
Szura D; Ozimek Ł; Przybyło M; Karłowicz-Bodalska K; Jaźwińska-Tarnawska E; Wiela-Hojeńska A; Han S
Acta Pol Pharm; 2014; 71(1):145-51. PubMed ID: 24779203
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery.
Ustündağ Okur N; Yavaşoğlu A; Karasulu HY
Chem Pharm Bull (Tokyo); 2014; 62(2):135-43. PubMed ID: 24492583
[TBL] [Abstract][Full Text] [Related]
4. Release and skin permeation studies of Naproxen from hydrophillic gels and effect of terpenes as enhancers on its skin permeation.
Ray S; Ghosal SK
Boll Chim Farm; 2003 Apr; 142(3):125-9. PubMed ID: 12806832
[TBL] [Abstract][Full Text] [Related]
5. Drug permeation through skin is inversely correlated with carrier gel rigidity.
Nguyen DV; Li F; Li H; Wong BS; Low CY; Liu XY; Kang L
Mol Pharm; 2015 Feb; 12(2):444-52. PubMed ID: 25495699
[TBL] [Abstract][Full Text] [Related]
6. Topical delivery of aceclofenac from lecithin organogels: preformulation study.
Shaikh IM; Jadhav KR; Gide PS; Kadam VJ; Pisal SS
Curr Drug Deliv; 2006 Oct; 3(4):417-27. PubMed ID: 17076644
[TBL] [Abstract][Full Text] [Related]
7. In vivo skin permeation of sodium naproxen formulated in pluronic F-127 gels: effect of Azone and Transcutol.
Escobar-Chávez JJ; Quintanar-Guerrero D; Ganem-Quintanar A
Drug Dev Ind Pharm; 2005 May; 31(4-5):447-54. PubMed ID: 16093210
[TBL] [Abstract][Full Text] [Related]
8. Rheological Characteristics of Novel Meloxicam-Loaded Complex Organogels Based on Fumed Silica and Poloxamer.
Osmalek T; Froelich A; Jadach B; Ancukiewicz K; Gadzinski P
Curr Drug Deliv; 2018; 15(5):686-697. PubMed ID: 29165081
[TBL] [Abstract][Full Text] [Related]
9. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
[TBL] [Abstract][Full Text] [Related]
10. Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation.
Rautio J; Nevalainen T; Taipale H; Vepsäläinen J; Gynther J; Laine K; Järvinen T
Eur J Pharm Sci; 2000 Aug; 11(2):157-63. PubMed ID: 10915963
[TBL] [Abstract][Full Text] [Related]
11. Development and Evaluation of Naproxen Sodium Gel Using Piper cubeba for Enhanced Transdermal Drug Delivery and Therapeutic Facilitation.
Patwardhan S; Patil M; Sockalingam A
Recent Pat Drug Deliv Formul; 2017; 11(1):28-35. PubMed ID: 28056749
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of a self-adhesive naproxen-loaded film prepared from a nanoparticle dispersion.
Ganem-Quintanar A; Silva-Alvarez M; Alvarez-Román R; Casas-Alancaster N; Cázares-Delgadillo J; Quintanar-Guerrero D
J Nanosci Nanotechnol; 2006; 6(9-10):3235-41. PubMed ID: 17048542
[TBL] [Abstract][Full Text] [Related]
13. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro skin permeation studies, and PLS-analysis of new naproxen derivatives.
Weber H; Steimer U; Mannhold R; Cruciani G
Pharm Res; 2001 May; 18(5):600-7. PubMed ID: 11465414
[TBL] [Abstract][Full Text] [Related]
15. Topical gels of etofenamate: in vitro and in vivo evaluation.
Marto J; Baltazar D; Duarte A; Fernandes A; Gouveia L; Militão M; Salgado A; Simões S; Oliveira E; Ribeiro HM
Pharm Dev Technol; 2015; 20(6):710-5. PubMed ID: 24798887
[TBL] [Abstract][Full Text] [Related]
16. Bio-based topical system for enhanced salicylic acid delivery: preparation and performance of gels.
Langasco R; Spada G; Tanriverdi ST; Rassu G; Giunchedi P; Özer Ö; Gavini E
J Pharm Pharmacol; 2016 Aug; 68(8):999-1009. PubMed ID: 27293193
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations.
Ustündağ Okur N; Apaydın S; Karabay Yavaşoğlu NÜ; Yavaşoğlu A; Karasulu HY
Int J Pharm; 2011 Sep; 416(1):136-44. PubMed ID: 21723930
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Skin Penetration Enhancer and Nanoemulsion Formulations Promote the Human Epidermal Permeation of Caffeine and Naproxen.
Abd E; Namjoshi S; Mohammed YH; Roberts MS; Grice JE
J Pharm Sci; 2016 Jan; 105(1):212-20. PubMed ID: 26554868
[TBL] [Abstract][Full Text] [Related]
19. Permeation of naproxen from saturated solutions and commercial formulations through synthetic membranes.
Farinha A; Toscano C; Campos R; Bica A; Hadgraft J
Drug Dev Ind Pharm; 2003 Apr; 29(4):489-94. PubMed ID: 12737541
[TBL] [Abstract][Full Text] [Related]
20. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
